PL2244737T3 - Kompozycje lotnego środka znieczulającego zawierające rozpuszczalniki ekstrakcyjne do znieczulania miejscowego i / albo zwalczania bólu - Google Patents

Kompozycje lotnego środka znieczulającego zawierające rozpuszczalniki ekstrakcyjne do znieczulania miejscowego i / albo zwalczania bólu

Info

Publication number
PL2244737T3
PL2244737T3 PL09703373T PL09703373T PL2244737T3 PL 2244737 T3 PL2244737 T3 PL 2244737T3 PL 09703373 T PL09703373 T PL 09703373T PL 09703373 T PL09703373 T PL 09703373T PL 2244737 T3 PL2244737 T3 PL 2244737T3
Authority
PL
Poland
Prior art keywords
pain relief
volatile anesthetic
regional anesthesia
anesthetic compositions
extractive solvents
Prior art date
Application number
PL09703373T
Other languages
English (en)
Inventor
Christopher C. Capelli
Phillip C. Phan
Allen W. Burton
Original Assignee
The Board Of Regents Of The University Of Texas System
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Board Of Regents Of The University Of Texas System filed Critical The Board Of Regents Of The University Of Texas System
Publication of PL2244737T3 publication Critical patent/PL2244737T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/02—Halogenated hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/08—Ethers or acetals acyclic, e.g. paraformaldehyde
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0085—Brain, e.g. brain implants; Spinal cord
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Anesthesiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Psychology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL09703373T 2008-01-22 2009-01-22 Kompozycje lotnego środka znieczulającego zawierające rozpuszczalniki ekstrakcyjne do znieczulania miejscowego i / albo zwalczania bólu PL2244737T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2266508P 2008-01-22 2008-01-22
PCT/US2009/031706 WO2009094459A1 (en) 2008-01-22 2009-01-22 Volatile anesthetic compositions comprising extractive solvents for regional anesthesia and/or pain relief
EP09703373.2A EP2244737B1 (en) 2008-01-22 2009-01-22 Volatile anesthetic compositions comprising extractive solvents for regional anesthesia and/or pain relief

Publications (1)

Publication Number Publication Date
PL2244737T3 true PL2244737T3 (pl) 2020-05-18

Family

ID=40456514

Family Applications (1)

Application Number Title Priority Date Filing Date
PL09703373T PL2244737T3 (pl) 2008-01-22 2009-01-22 Kompozycje lotnego środka znieczulającego zawierające rozpuszczalniki ekstrakcyjne do znieczulania miejscowego i / albo zwalczania bólu

Country Status (10)

Country Link
US (3) US9675544B2 (pl)
EP (2) EP2244737B1 (pl)
JP (2) JP5789100B2 (pl)
CN (2) CN107661293A (pl)
AU (1) AU2009206390B2 (pl)
CA (1) CA2712731C (pl)
DK (1) DK2244737T3 (pl)
ES (1) ES2732444T3 (pl)
PL (1) PL2244737T3 (pl)
WO (1) WO2009094459A1 (pl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010504359A (ja) 2006-09-20 2010-02-12 ザ ボード オブ リージェンツ オブ ザ ユニバーシティー オブ テキサス システム 局部麻酔および／または疼痛緩和のための、揮発性麻酔剤を送達するための方法
WO2009094460A2 (en) 2008-01-22 2009-07-30 Vapogenix, Inc. Volatile anesthetic compositions and methods of use
WO2010025505A1 (en) * 2008-09-04 2010-03-11 Phebra Pty Ltd Analgesia by transmucosal administration
EP2427243A4 (en) 2009-05-05 2012-11-21 Vapogenix Inc NEW FORMULATIONS OF VOLATILE ANESTHETICS AND METHOD OF ADMINISTRATION
US9968540B2 (en) * 2011-06-24 2018-05-15 Vapogenix, Inc. Formulations and methods for treating dermatological disorders or diseases
US9308269B2 (en) 2011-07-27 2016-04-12 University Of Miami Stable liquid formulations of volatile gas anesthetics
PL2968214T3 (pl) 2013-03-15 2021-11-02 Newvapogen, Inc. Nowe kompozycje przeciwbólowe
JP7044702B2 (ja) 2015-07-20 2022-03-30 メディカル、ディベロップメンツ、インターナショナル、リミテッド 吸入可能な液体のための吸入器デバイス
JP7001589B2 (ja) 2015-07-20 2022-01-19 メディカル、ディベロップメンツ、インターナショナル、リミテッド 吸入可能な液体のための吸入器デバイス
WO2017011867A1 (en) 2015-07-20 2017-01-26 Medical Developments International Limited Inhaler device for inhalable liquids
US9554998B1 (en) 2015-08-04 2017-01-31 Damaso Fernandez Gines Composition of analgesic bioadhesive healing microspheres
WO2018045418A1 (en) 2016-09-06 2018-03-15 Medical Developments International Limited Inhaler device for inhalable liquids
CN115671084B (zh) * 2021-07-21 2023-09-15 四川大学华西医院 甲氧氟烷在制备抗肝包虫病的药物中的应用

Family Cites Families (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB445289A (en) 1934-10-04 1936-04-06 Karl Merck manufacture of stabilised preparations of divinyl ether
US3097133A (en) * 1959-12-21 1963-07-09 Ici Ltd Anaesthetic 1: 1: 1: 3: 3: 3-hexafluoro-2-halopropane
BE786675A (fr) 1971-08-02 1973-01-25 Airco Inc Separation d'oxydes d'alkyle halogenes par distillation azeotropique.
US4109651A (en) 1975-11-19 1978-08-29 Steigerwald Allan M Anesthetic gas exhaust system
US4954487A (en) * 1979-01-08 1990-09-04 The Procter & Gamble Company Penetrating topical pharmaceutical compositions
US4453951A (en) 1980-07-09 1984-06-12 General Electric Co. Process for the production of silicone carbide composite
SE8008962L (sv) 1980-12-18 1982-06-19 Erik Allan Lindkvist Anordning vid narkosmask
US4879062A (en) * 1981-10-20 1989-11-07 Adamantech, Inc. Preparation of a gel having gas transporting capability
US4622219A (en) * 1983-06-17 1986-11-11 Haynes Duncan H Method of inducing local anesthesia using microdroplets of a general anesthetic
US4744989A (en) * 1984-02-08 1988-05-17 E. R. Squibb & Sons, Inc. Method of preparing liposomes and products produced thereby
US4837163A (en) * 1987-10-02 1989-06-06 Tsuyoshi Ohnishi Simple blood test for diagnosing malignant hyperthermia
US4994025A (en) * 1989-08-29 1991-02-19 Baxter International Inc. Method of dissolving cholesterol-rich calculi with short chain halogenated organic solvents and cosolvents
US5466468A (en) 1990-04-03 1995-11-14 Ciba-Geigy Corporation Parenterally administrable liposome formulation comprising synthetic lipids
US5677290A (en) 1990-05-10 1997-10-14 Fukunaga; Atsuo F. Therapeutic use of adenosine compounds as surgical anesthetics
US5679650A (en) 1993-11-24 1997-10-21 Fukunaga; Atsuo F. Pharmaceutical compositions including mixtures of an adenosine compound and a catecholamine
US5114714A (en) 1990-11-29 1992-05-19 Sepracor, Inc. Methods of use and compositions of (r)-isoflurane and (r)-desflurane
DE4105972C2 (de) 1991-02-26 1999-06-02 Draegerwerk Ag Narkosemitteldosiervorrichtung
BE1005163A3 (fr) 1991-08-01 1993-05-11 Solvay Compositions contenant un ether fluore et utilisation de ces compositions.
GB9202238D0 (en) 1992-02-03 1992-03-18 Wellcome Found Compounds
US5230778A (en) * 1992-05-01 1993-07-27 Gavlin Associates Purification of isoflurane by extractive distillation
US5916596A (en) 1993-02-22 1999-06-29 Vivorx Pharmaceuticals, Inc. Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
GB9308306D0 (en) 1993-04-22 1993-06-09 Univ Aberdeen Analgesic composition
GB9312578D0 (en) 1993-06-18 1993-08-04 Isis Innovation Determining gas concentration
WO1995004051A1 (en) 1993-07-30 1995-02-09 The Wellcome Foundation Limited Piperazine compounds used in therapy
GB9423542D0 (en) 1994-11-22 1995-01-11 Marples Brian A Pharmaceutical compounds
US5563153A (en) * 1995-02-22 1996-10-08 University Of Kansas Medical Center Sterile topical anesthetic gel
US5568910A (en) 1995-03-02 1996-10-29 Delmarva Laboratories, Inc. Anesthesia machine
US6248788B1 (en) 1996-11-06 2001-06-19 The Regents Of The University Of California Therapeutic method with capsaicin and capasicin analogs
US5874469A (en) * 1996-01-05 1999-02-23 Alcon Laboratories, Inc. Fluoroalkyl hydrocarbons for administering water insoluble or unstable drugs
US5861175A (en) * 1996-03-15 1999-01-19 Alliance Pharmaceutical Corp. Use of fluorocarbons for diagnosis and treatment of articular disorders
US5919826A (en) 1996-10-24 1999-07-06 Algos Pharmaceutical Corporation Method of alleviating pain
US5990176A (en) * 1997-01-27 1999-11-23 Abbott Laboratories Fluoroether compositions and methods for inhibiting their degradation in the presence of a Lewis acid
US20030212123A1 (en) 1997-05-05 2003-11-13 Pfizer Inc. COX-2 selective carprofen for treating pain and inflammation in dogs
JP2003526594A (ja) 1997-07-14 2003-09-09 アドラー コーポレーション カッパ・アゴニスト抗掻痒薬学的製剤およびそれにより掻痒を治療する方法
US20030185761A1 (en) * 1997-10-01 2003-10-02 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating pain
US5976072A (en) 1998-01-29 1999-11-02 Johns Hopkins University Copa method for fiberoptic endotracheal intubation
AR015744A1 (es) 1998-04-01 2001-05-16 Orion Corp Uso de dexmedetomidina para sedacion en terapia intensiva
US6830581B2 (en) 1999-02-09 2004-12-14 Innercool Therspies, Inc. Method and device for patient temperature control employing optimized rewarming
US6869440B2 (en) 1999-02-09 2005-03-22 Innercool Therapies, Inc. Method and apparatus for patient temperature control employing administration of anti-shivering agents
NZ515143A (en) * 1999-06-10 2004-05-28 Bridge Pharma Inc Aminoindane piperidine compounds as dermal anesthetic agents
US6706034B1 (en) 1999-12-30 2004-03-16 Advanced Cardiovascular Systems, Inc. Process for agent retention in biological tissues
US6669954B2 (en) 2000-01-25 2003-12-30 John R. Crison Controlled release of drugs
DE60131393D1 (de) 2000-05-02 2007-12-27 Action Pharma As Verfahren zur behandlung von erkrankungen assoziiert mit akuten entzündung unter nichtischämischen zustände
US6770636B2 (en) 2000-08-18 2004-08-03 Boehringer Ingelheim Pharma Kg Phenyl-and phenylalkyl-substituted ethanolamines and ethylenediamines
US20030152637A1 (en) * 2001-01-25 2003-08-14 Mark Chasin Local anesthetic, and method of use
AU2002256359A1 (en) 2001-04-24 2002-11-05 Epigenesis Pharmaceuticals, Inc. Antisense and anti-inflammatory based compositions to treat respiratory disorders
WO2003059347A1 (en) 2002-01-10 2003-07-24 Pharmacia & Upjohn Company Use of cox-2 inhibitors in combination with antiviral agents for the treatment of papilloma virus infections
US20030181426A1 (en) 2002-02-11 2003-09-25 Eisenach James C. Compositions and methods for treating pain using cyclooxygenase-1 inhibitors
AU2003219167A1 (en) 2002-03-19 2003-09-29 Genset Sa Treatment of metabolic disorders with a tnf receptor family member (fradj and/or cryptic) agonists or antagonists
ATE469913T1 (de) 2002-08-10 2010-06-15 Univ Yale Antagonisten des nogo-rezeptors
ATE546136T1 (de) * 2002-10-11 2012-03-15 Baxter Int Kardioprotektions- und neuroprotektionsverfahren durch intravenöse verabreichung von halogenierten flüchtigen narkosemitteln
CN1777425A (zh) 2003-03-28 2006-05-24 阿卡蒂亚药品公司 用于疼痛控制的毒蕈碱性m1受体激动剂
WO2004100868A2 (en) 2003-04-23 2004-11-25 Abbott Laboratories Method of treating transplant rejection
US20030173287A1 (en) 2003-05-06 2003-09-18 Johnston Arthur W Filter devices and methods of use
MXPA05012305A (es) 2003-05-16 2006-04-18 Acorda Therapeutics Inc Composiciones y metodos para el tratamiento de lesiones del snc.
JP2007501612A (ja) 2003-08-07 2007-02-01 バイオジェン・アイデック・エムエイ・インコーポレイテッド Ｎｏｇｏ受容体アンタゴニスト
DE602004013792D1 (de) 2003-08-15 2008-06-26 Ab Science Verwendung von c-kit-inhibitoren für die behandlung von typ-2-diabetes
JP2007525972A (ja) 2003-08-29 2007-09-13 チルドレンズ メディカル センター コーポレーション エンドスタチンのｎ末端からの抗血管新生性ペプチド
BR0303489A (pt) * 2003-09-10 2005-07-05 Cristalia Prod Quimicos Farm Composição farmacêutica estabilizada de composto flúor-éter e método para inibir a degradação de composto flúor-éter. uso de agente estabilizante para inibir a degradação de composto flúor éter
MXPA06000803A (es) * 2003-09-10 2006-08-23 Cristalia Prod Quimicos Farm Composicion farmaceutica estable del compuesto de fluoroeter para uso anestesico, metodo para estabilizar un compuesto de fluoroeter, uso del agente estabilizador para evitar la degradacion de un compuesto de fluoroeter.
KR20060088885A (ko) 2003-09-25 2006-08-07 아카디아 파마슈티칼스 인코포레이티드 뉴로펩티드 ｆｆ 리셉터 2의 작용제를 이용한 신경병증성통증 치료 방법
WO2005070333A1 (en) * 2004-01-13 2005-08-04 Orthobiologica, Inc. Drug delivery to a joint
US20060051413A1 (en) * 2004-09-08 2006-03-09 Chow Sing S M Method of enhancing absorptions of transmucosal administration formulations
US8557861B2 (en) * 2004-09-28 2013-10-15 Mast Therapeutics, Inc. Low oil emulsion compositions for delivering taxoids and other insoluble drugs
US20060198891A1 (en) * 2004-11-29 2006-09-07 Francois Ravenelle Solid formulations of liquid biologically active agents
JP2009519957A (ja) * 2005-12-14 2009-05-21 ザーズ， インコーポレイテッド 薬物の皮膚送達のためのスプレイ−オン処方物および方法
CA2636601C (en) * 2006-01-13 2019-03-19 Cosmas Therapeutics Development Inc. Novel melatonin ligands having antidepressant activity as well as sleep inducing properties
SI1976521T1 (sl) * 2006-01-25 2015-06-30 Insys Therapeutics, Inc. Podjezično fentanilno pršilo
JP2010504359A (ja) 2006-09-20 2010-02-12 ザ ボード オブ リージェンツ オブ ザ ユニバーシティー オブ テキサス システム 局部麻酔および／または疼痛緩和のための、揮発性麻酔剤を送達するための方法
US9000048B2 (en) * 2006-11-28 2015-04-07 Wisconsin Alumni Research Foundation Fluoropolymer-based emulsions for the intravenous delivery of fluorinated volatile anesthetics
WO2009094460A2 (en) 2008-01-22 2009-07-30 Vapogenix, Inc. Volatile anesthetic compositions and methods of use
EP2427243A4 (en) 2009-05-05 2012-11-21 Vapogenix Inc NEW FORMULATIONS OF VOLATILE ANESTHETICS AND METHOD OF ADMINISTRATION

Also Published As

Publication number Publication date
JP5789100B2 (ja) 2015-10-07
US20110039944A1 (en) 2011-02-17
JP2016026147A (ja) 2016-02-12
EP2244737B1 (en) 2019-04-10
CN107661293A (zh) 2018-02-06
US20200253864A1 (en) 2020-08-13
US9675544B2 (en) 2017-06-13
ES2732444T3 (es) 2019-11-22
US20180015030A1 (en) 2018-01-18
WO2009094459A1 (en) 2009-07-30
EP3581169A1 (en) 2019-12-18
AU2009206390A1 (en) 2009-07-30
US10420720B2 (en) 2019-09-24
AU2009206390B2 (en) 2014-10-30
JP2011510091A (ja) 2011-03-31
CN102014961B (zh) 2017-10-13
CA2712731A1 (en) 2009-07-30
CA2712731C (en) 2016-05-03
DK2244737T3 (da) 2019-07-08
CN102014961A (zh) 2011-04-13
JP6033932B2 (ja) 2016-11-30
EP2244737A1 (en) 2010-11-03

Similar Documents

Publication Publication Date Title
DK2244737T3 (da) Flygtige anæstetiske sammensætninger omfattende ekstraktionsopløsningsmidler til regional anæstesi og/eller smertelindring
PL2081562T3 (pl) Sposoby dostarczania lotnych środków znieczulających do znieczulenia regionalnego i/lub zmniejszania bólu
PL2244783T3 (pl) Kompozycje lotnego anestetyku i sposoby stosowania
IL275854A (en) Pharmaceutical composition and its administration
EP2367589A4 (en) SURGICAL MASK COMBINED WITH ANESTHESIA AND GAS RECOVERY
GB2462789B (en) Procedures and compositions for reservoir protection
LT2224917T (lt) Kompozicija, apimanti nikotiną ir opipramolį, ir jos panaudojimas
IL258730A (en) Preparations and methods for the treatment of microbial disorders
PL2170280T3 (pl) Kompozycja do wdychania zawierająca nikotynę
IL210810A0 (en) Compositions for the treatment of pain and/or inflamtion
EP2291157A4 (en) COMPOSITIONS AND METHODS FOR TRANSDERING DELIVERY OF PHARMACEUTICAL COMPOUNDS
EP2205300A4 (en) MEDICAL INHALATION DEVICES AND COMPONENTS THEREOF
EP2336109A4 (en) NOVEL PYRROLINONE DERIVATIVE AND DRUG COMPOSITION CONTAINING THE SAME
ZA201000224B (en) Pharmaceutical preparations containing highly volatile silicones
IL206000A0 (en) Pharmaceutical compositions for treating depression and anxiety
ZA200807486B (en) Medicament formulations comprising fluoroquinolones
GB2462896B (en) Wick for an anaesthetic vaporiser
EP2185144A4 (en) COMPOSITION FOR PREVENTING OR TREATING BONE METABOLISM DISORDER CONTAINING D-PINITOL AS ACTIVE INGREDIENT
GB2445655B (en) Laryngeal mask assemblies and obturators
SI2158908T1 (sl) Sestavek za transdermalno dajanje
GB2456528B (en) Antioxidant for use in cosmetic, medicated and pharmaceutical compositions
IL173814A0 (en) Vaporizer for volatile anesthetics
IL166242A0 (en) Vaporizer for volatile anesthetics
SG10201405262SA (en) Pharmaceutical compositions for treating depression and anxiety
GB0714091D0 (en) Medical compositions and devices